Abstract
The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions.
Original language | English (US) |
---|---|
Pages (from-to) | 718-720 |
Number of pages | 3 |
Journal | Infection Control and Hospital Epidemiology |
Volume | 38 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2017 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved.